These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38516474)

  • 21. Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa.
    Kitamura A; Hoshino K; Kimura Y; Hayakawa I; Sato K
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1467-71. PubMed ID: 7492087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoroquinolones: is there a different mechanism of action and resistance against Streptococcus pneumoniae?
    Harding I; Simpson I
    J Chemother; 2000 Oct; 12 Suppl 4():7-15. PubMed ID: 11131958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anti-methicillin-resistant Staphylococcus aureus quinolone WCK 771 has potent activity against sequentially selected mutants, has a narrow mutant selection window against quinolone-resistant Staphylococcus aureus, and preferentially targets DNA gyrase.
    Bhagwat SS; Mundkur LA; Gupte SV; Patel MV; Khorakiwala HF
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3568-79. PubMed ID: 16940059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance.
    Bush NG; Diez-Santos I; Abbott LR; Maxwell A
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33271787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of resistance to fluoroquinolones.
    Rattan A
    Natl Med J India; 1999; 12(4):162-4. PubMed ID: 10573971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
    Ferrero L; Cameron B; Manse B; Lagneaux D; Crouzet J; Famechon A; Blanche F
    Mol Microbiol; 1994 Aug; 13(4):641-53. PubMed ID: 7997176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sitafloxacin: antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV.
    Deguchi T; Kikuchi M; Yasuda M; Ito S
    J Infect Chemother; 2015 Jan; 21(1):74-5. PubMed ID: 25245990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoroquinolones: structure and target sites.
    Higgins PG; Fluit AC; Schmitz FJ
    Curr Drug Targets; 2003 Feb; 4(2):181-90. PubMed ID: 12558069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of action of antimicrobials: focus on fluoroquinolones.
    Hooper DC
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S9-S15. PubMed ID: 11249823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Action of quinolones against Staphylococcus aureus topoisomerase IV: basis for DNA cleavage enhancement.
    Anderson VE; Zaniewski RP; Kaczmarek FS; Gootz TD; Osheroff N
    Biochemistry; 2000 Mar; 39(10):2726-32. PubMed ID: 10704224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China.
    Zeng L; Zhang J; Li C; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Zhang X
    Infect Genet Evol; 2020 Aug; 82():104319. PubMed ID: 32278145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Campylobacter jejuni DNA gyrase as the target of quinolones.
    Changkwanyeun R; Usui M; Kongsoi S; Yokoyama K; Kim H; Suthienkul O; Changkaew K; Nakajima C; Tamura Y; Suzuki Y
    J Infect Chemother; 2015 Aug; 21(8):604-9. PubMed ID: 26096494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.
    Okumura R; Hirata T; Onodera Y; Hoshino K; Otani T; Yamamoto T
    J Antimicrob Chemother; 2008 Jul; 62(1):98-104. PubMed ID: 18390884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones.
    Malik M; Zhao X; Drlica K
    Mol Microbiol; 2006 Aug; 61(3):810-25. PubMed ID: 16803589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of action of and resistance to quinolones.
    Fàbrega A; Madurga S; Giralt E; Vila J
    Microb Biotechnol; 2009 Jan; 2(1):40-61. PubMed ID: 21261881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones.
    Pan XS; Fisher LM
    Antimicrob Agents Chemother; 1997 Feb; 41(2):471-4. PubMed ID: 9021211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoroquinolone-induced Glycaemic Aberrations: Could Quinolones be Repurposed to Serve as New Antidiabetic Agents?
    Ayodele O; Khanye S; Mothibe M; Sibiya N
    Curr Rev Clin Exp Pharmacol; 2023; 18(1):12-21. PubMed ID: 35184708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of mutations in DNA gyrase genes on quinolone resistance in Campylobacter jejuni.
    Changkwanyeun R; Yamaguchi T; Kongsoi S; Changkaew K; Yokoyama K; Kim H; Suthienkul O; Usui M; Tamura Y; Nakajima C; Suzuki Y
    Drug Test Anal; 2016 Oct; 8(10):1071-1076. PubMed ID: 26857529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoroquinolones as chemotherapeutics against mycobacterial infections.
    Jacobs MR
    Curr Pharm Des; 2004; 10(26):3213-20. PubMed ID: 15544510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological Effects of Quinolones: A Family of Broad-Spectrum Antimicrobial Agents.
    Millanao AR; Mora AY; Villagra NA; Bucarey SA; Hidalgo AA
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.